Showing results (1-10 of 71) with videos related to
Sort By:
Pageof 8
Bioscience Reports|August 2, 2019
Genetic polymorphism and transcriptional regulation of <i>CREBBP</i> gene in patient with diffuse large B-cell lymphomaHaifeng Zhao, Yutian Kan, Xinyuan Wang, et al.International Journal of Nanomedicine|March 19, 2021
Cancer Cell Membrane Camouflaged Mesoporous Silica Nanoparticles Combined with Immune Checkpoint Blockade for Regulating Tumor Microenvironment and Enhancing Antitumor TherapyPeiqi Zhao, Lihua Qiu, Shiyong Zhou, et al.International Journal of Nanomedicine|January 16, 2013
A phase I pharmacokinetic study of ursolic acid nanoliposomes in healthy volunteers and patients with advanced solid tumorsZhongling Zhu, Zhengzi Qian, Zhao Yan, et al.Biomed Research International|April 14, 2015
Gemcitabine, navelbine, and doxorubicin as treatment for patients with refractory or relapsed T-cell lymphomaZhengzi Qian, Zheng Song, Huilai Zhang, et al.Journal of Drug Targeting|May 8, 2020
Combination immunotherapy of oncolytic virus nanovesicles and PD-1 blockade effectively enhances therapeutic effects and boosts antitumour immune responseWei Ji, Lanfang Li, Shiyong Zhou, et al.Leukemia Research|November 5, 2010
Lenalidomide synergizes with dexamethasone to induce growth arrest and apoptosis of mantle cell lymphoma cells in vitro and in vivoZhengzi Qian, Liang Zhang, Zhen Cai, et al.Biomed Research International|April 14, 2015
A phase I trial to evaluate the multiple-dose safety and antitumor activity of ursolic acid liposomes in subjects with advanced solid tumorsZhengzi Qian, Xianhuo Wang, Zheng Song, et al.International Journal of Nanomedicine|January 14, 2022
Hybrid Membrane Nanovaccines Combined with Immune Checkpoint Blockade to Enhance Cancer ImmunotherapyPeiqi Zhao, Yuanlin Xu, Wei Ji, et al.Oncology Letters|February 22, 2021
A modified prognostic model in patients with diffuse large B-cell lymphoma treated with immunochemotherapyPeiqi Zhao, Lei Zhu, Lanfang Li, et al.Hematological Oncology|July 31, 2019
CD5 expression correlates with inferior survival and enhances the negative effect of p53 overexpression in diffuse large B-cell lymphomaPeiqi Zhao, Lanfang Li, Shiyong Zhou, et al.Pageof 8